TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Dating Sites: Best, Worst & Weirdest
STOCKS

Poniard Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript

  • By Seeking Alpha
  • Nov 9, 2010 7:22 PM EST
STOCKS

Poniard Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript

  • By Seeking Alpha
  • Aug 9, 2010 6:48 PM EDT
OPINION

Stocks Under $5 With the Most Sell Ratings

  • By Robert Holmes
  • Jun 24, 2010 7:01 AM EDT
STOCKS

Poniard Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript

  • By Seeking Alpha
  • May 10, 2010 8:12 PM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Poniard, Xfone: Early Volume Plays

  • By Robert Holmes
  • Mar 24, 2010 9:35 AM EDT
Dating Sites: Best, Worst & Weirdest
OPINION

Cell Therapeutics, Zoom Technologies: Midday Volume Plays

  • By Robert Holmes
  • Mar 8, 2010 11:59 AM EST
Novartis Commits $500 Million to Russia
STOCKS

Medivation: Biotech Stock Mailbag

  • By Adam Feuerstein
  • Mar 3, 2010 11:54 AM EST
STOCKS

Antigenics Files $100 Million Mixed Shelf: BioBuzz

  • By Adam Feuerstein
  • Jan 25, 2010 12:04 PM EST
Dating Sites: Best, Worst & Weirdest
STOCKS

New Gold, Poniard: Early Volume Plays

  • By Robert Holmes
  • Jan 25, 2010 7:24 AM EST
Neurocrine Licenses Drug to Abbott:BioBuzz
STOCKS

Poniard Drug Safe, Less Effective: BioBuzz

  • By Adam Feuerstein
  • Jan 25, 2010 6:14 AM EST
Dating Sites: Best, Worst & Weirdest
STOCKS

Poniard, Blockbuster: Late Day Volume Plays

  • By Robert Holmes
  • Jan 22, 2010 3:16 PM EST
STOCKS

Biotech Stock Mailbag: Novelos Therapeutics

  • By Adam Feuerstein
  • Jan 8, 2010 7:00 AM EST
Dating Sites: Best, Worst & Weirdest
STOCKS

ARCA, FortuNet: Midday Volume Plays

  • By Robert Holmes
  • Nov 23, 2009 1:25 PM EST
Vertex Cures Hard-to-Treat Hep C Patients
STOCKS

Poniard Finds Cash to Keep Lights On: BioBuzz

  • By Adam Feuerstein
  • Nov 23, 2009 12:59 PM EST
STOCKS

Biotech Stock Mailbag: FDA Playbook

  • By Adam Feuerstein
  • Nov 20, 2009 6:01 AM EST
Dating Sites: Best, Worst & Weirdest
STOCKS

Poniard, Netlist: Early Volume Plays

  • By Robert Holmes
  • Nov 18, 2009 8:57 AM EST
Lilly Sinks as Cholesterol-Lowering Pill Trial Shut Down
STOCKS

Poniard's CEO Pulls a Belichick: BioBuzz

  • By Adam Feuerstein
  • Nov 16, 2009 11:59 AM EST
Pfizer to Buy King Pharma for $3.6B Cash
STOCKS

A Closer Look at Cardium's Wound-Healing Drug: BioBuzz

  • By Adam Feuerstein
  • Nov 16, 2009 10:51 AM EST
Vertex Cures Hard-to-Treat Hep C Patients
STOCKS

Cell Therapeutics Lavishes Free Stock on Execs: BioBuzz

  • By Adam Feuerstein
  • Nov 16, 2009 9:23 AM EST
Merck to Trim Staff as Profit Meets Views
STOCKS

Poniard Cancer Drug Fails Pivotal Study: BioBuzz

  • By Adam Feuerstein
  • Nov 16, 2009 8:01 AM EST
STOCKS

Biotech Stock Mailbag: Poniard Predictions

  • By Adam Feuerstein
  • Nov 6, 2009 7:00 AM EST
STOCKS

Biotech Calendar: Key Dates for November

  • By Adam Feuerstein
  • Nov 2, 2009 7:12 AM EST
STOCKS

Biotech Calendar: Key Upcoming Trials

  • By Adam Feuerstein
  • Oct 23, 2009 6:00 AM EDT
Biotech String: Editas IPO Terms, Rooting for Shkreli in DC
STOCKS

Biotech's Hot and Getting Hotter

  • By Adam Feuerstein
  • Aug 3, 2009 8:57 AM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Four Must-See Charts: Biotech Stocks

  • By Stockpickr Staff
  • Jun 18, 2009 3:34 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.